Neomycin and pentagalloyl glucose enhanced cross-linking for elastin and glycosaminoglycans preservation in bioprosthetic heart valves

Journal of Biomaterials Applications

Volumn 28, Issue 5, 2014, Pages 757-766

  Tripi, Daniel R ^a   Vyavahare, Naren R ^a  

^a Clemson University   (United States)

Author keywords

extracellular matrix; glycosaminoglycans; Heart valve implant; tissue biomechanics; tissue preservation

Indexed keywords

EXTRACELLULAR MATRICES; GLYCOSAMINOGLYCANS; HEART VALVES; TISSUE BIOMECHANICS; TISSUE PRESERVATION;

ANTIBIOTICS; BIOMINERALIZATION; DURABILITY; ELASTIC MODULI; ELASTIN; GLUCOSE; GLYCOPROTEINS;

TISSUE;

ELASTIN; GLUCOSE PENTAGALLATE; GLUTARALDEHYDE; GLYCOSAMINOGLYCAN; NEOMYCIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA VALVE; AORTA VALVE REPLACEMENT; ARTICLE; BIOCOMPATIBILITY; BIOMECHANICS; CALCIFICATION; CONTROLLED STUDY; DRUG STABILITY; ENZYME DEGRADATION; EXTRACELLULAR MATRIX; HEART VALVE BIOPROSTHESIS; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; ORGAN PRESERVATION; PRIORITY JOURNAL; PROTEIN CROSS LINKING; RAT; STORAGE; SWINE; TENSILE STRENGTH; YOUNG MODULUS;

EXTRACELLULAR MATRIX; GLYCOSAMINOGLYCANS; HEART VALVE IMPLANT; TISSUE BIOMECHANICS; TISSUE PRESERVATION;

BIOPROSTHESIS; CALCINOSIS; CALORIMETRY, DIFFERENTIAL SCANNING; ELASTIN; GLYCOSAMINOGLYCANS; HEART VALVE PROSTHESIS; HYDROLYZABLE TANNINS; NEOMYCIN; PROTEIN DENATURATION;

EID: 84891471426     PISSN: 08853282     EISSN: 15308022     Source Type: Journal    
DOI: 10.1177/0885328213479047     Document Type: Article

References (35)

1. Schoen FJ, Levy RJ. Tissue heart valves: current challenges and future research perspectives. J Biomed Mater Res. 1999 ; 47 (4). 439-465
2. Johansen P, Andersen TS, Hasenkam JM, et al. In-vivo prediction of cavitation near a Medtronic Hall valve. J Heart Valve Dis. 2004 ; 13 (4). 651-658
3. Vesely I. The evolution of bioprosthetic heart valve design and its impact on durability. Cardiovasc Pathol. 2003 ; 12 (5). 277-286
4. Munnelly AE, Cochrane L, Leong J, et al. Porcine vena cava as an alternative to bovine pericardium in bioprosthetic percutaneous heart valves. Biomaterials. 2012 ; 33 (1). 1-8
5. Siddiqui RF, Abraham JR, Butany J. Bioprosthetic heart valves: modes of failure. Histopathology. 2009 ; 55 (2). 135-144
6. Lee TC, Midura RJ, Hascall VC, et al. The effect of elastin damage on the mechanics of the aortic valve. J Biomech. 2001 ; 34 (2). 203-210
7. Lovekamp JJ, Simionescu DT, Mercuri JJ, et al. Stability and function of glycosaminoglycans in porcine bioprosthetic heart valves. Biomaterials. 2006 ; 27 (8). 1507-1518
8. Vyavahare N, Ogle M, Schoen FJ, et al. Mechanisms of bioprosthetic heart valve failure: fatigue causes collagen denaturation and glycosaminoglycan loss. J Biomed Mater Res. 1999 ; 46 (1). 44-50
9. Mirnajafi A, Zubiate B, Sacks MS. Effects of cyclic flexural fatigue on porcine bioprosthetic heart valve heterograft biomaterials. J Biomed Mater Res A. 2010 ; 94 (1). 205-213
10. Shah SR, Vyavahare NR. The effect of glycosaminoglycan stabilization on tissue buckling in bioprosthetic heart valves. Biomaterials. 2008 ; 29 (11). 1645-1653
11. Schoen FJ. Cardiac valves and valvular pathology: update on function, disease, repair, and replacement. Cardiovasc Pathol. 2005 ; 14 (4). 189-194
12. Raghavan D, Starcher BC, Vyavahare NR. Neomycin binding preserves extracellular matrix in bioprosthetic heart valves during in vitro cyclic fatigue and storage. Acta Biomater. 2009 ; 5 (4). 983-992
13. Raghavan D, Shah SR, Vyavahare NR. Neomycin fixation followed by ethanol pretreatment leads to reduced buckling and inhibition of calcification in bioprosthetic valves. J Biomed Mater Res B Appl Biomater. 2010 ; 92 (1). 168-177
14. Friebe VM, Mikulis B, Kole S, et al. Neomycin enhances extracellular matrix stability of glutaraldehyde crosslinked bioprosthetic heart valves. J Biomed Mater Res B Appl Biomater. 2011 ; 99 (2). 217-229
15. Raghavan D, Simionescu DT, Vyavahare NR. Neomycin prevents enzyme-mediated glycosaminoglycan degradation in bioprosthetic heart valves. Biomaterials. 2007 ; 28 (18). 2861-2868
16. Leong J, Munnelly A, Liberio B et al. Neomycin and carbodiimide crosslinking as an alternative to glutaraldehyde for enhanced durability of bioprosthetic heart valves. J Biomater Appl 2011. Epub ahead of print.
17. Isenburg JC, Karamchandani NV, Simionescu DT, et al. Structural requirements for stabilization of vascular elastin by polyphenolic tannins. Biomaterials. 2006 ; 27 (19). 3645-3651
18. Lee JS, Basalyga DM, Simionescu A, et al. Elastin calcification in the rat subdermal model is accompanied by up-regulation of degradative and osteogenic cellular responses. Am J Pathol. 2006 ; 168 (2). 490-498
19. Farndale RW, Buttle DJ, Barrett AJ. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta. 1986 ; 883 (2). 173-177
20. Vyavahare N, Hirsch D, Lerner E, et al. Prevention of bioprosthetic heart valve calcification by ethanol preincubation. Efficacy and mechanisms. Circulation. 1997 ; 95 (2). 479-488
21. Chen W, Schoen FJ, Levy RJ. Mechanism of efficacy of 2-amino oleic acid for inhibition of calcification of glutaraldehyde-pretreated porcine bioprosthetic heart valves. Circulation. 1994 ; 90 (1). 323-329
22. Mercuri JJ, Lovekamp JJ, Simionescu DT, et al. Glycosaminoglycan-targeted fixation for improved bioprosthetic heart valve stabilization. Biomaterials. 2007 ; 28 (3). 496-503
23. Lovekamp J, Vyavahare N. Periodate-mediated glycosaminoglycan stabilization in bioprosthetic heart valves. J Biomed Mater Res. 2001 ; 56 (4). 478-486
24. Vesely I. The role of elastin in aortic valve mechanics. J Biomech. 1998 ; 31 (2). 115-123
25. Bailey MT, Pillarisetti S, Xiao H, et al. Role of elastin in pathologic calcification of xenograft heart valves. J Biomed Mater Res A. 2003 ; 66 (1). 93-102
26. Vyavahare N, Ogle M, Schoen FJ, et al. Elastin calcification and its prevention with aluminum chloride pretreatment. Am J Pathol. 1999 ; 155 (3). 973-982
27. Isenburg JC, Simionescu DT, Vyavahare NR. Elastin stabilization in cardiovascular implants: improved resistance to enzymatic degradation by treatment with tannic acid. Biomaterials. 2004 ; 25 (16). 3293-3302
28. Isenburg JC, Simionescu DT, Vyavahare NR. Tannic acid treatment enhances biostability and reduces calcification of glutaraldehyde fixed aortic wall. Biomaterials. 2005 ; 26 (11). 1237-1245
29. Simionescu DT, Lovekamp JJ, Vyavahare NR. Degeneration of bioprosthetic heart valve cusp and wall tissues is initiated during tissue preparation: an ultrastructural study. J Heart Valve Dis. 2003 ; 12 (2). 226-234
30. Lowther DA, Preston BN, Meyer FA. Isolation and properties of chondroitin sulphates from bovine heart valves. Biochem J. 1970 ; 118 (4). 595-601
31. Salmen S, Hoechstetter J, Käsbauer C, et al. Sulphated oligosaccharides as inhibitors of hyaluronidases from bovine testis, bee venom and Streptococcus agalactiae. Planta Med. 2005 ; 71 (8). 727-732
32. Vyavahare NR, Hirsch D, Lerner E, et al. Prevention of calcification of glutaraldehyde-crosslinked porcine aortic cusps by ethanol preincubation: mechanistic studies of protein structure and water-biomaterial relationships. J Biomed Mater Res. 1998 ; 40 (4). 577-585
33. Christie GW, Barratt-Boyes BG. Age-dependent changes in the radial stretch of human aortic valve leaflets determined by biaxial testing. Ann Thorac Surg. 1995 ; 60: S156-8
34. Stella JA, Sacks MS. On the biaxial mechanical properties of the layers of the aortic valve leaflet. J Biomech Eng. 2007 ; 129 (5). 757-766
35. Sacks MS, David Merryman W, Schmidt DE. On the biomechanics of heart valve function. J Biomech. 2009 ; 42 (12). 1804-1824